Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Dow
Harvard Business School
McKesson
Johnson and Johnson

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Curium Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CURIUM, and what generic and branded alternatives to CURIUM drugs are available?

CURIUM has fourteen approved drugs.



Summary for Curium
US Patents:0
Tradenames:13
Ingredients:13
NDAs:14

Drugs and US Patents for Curium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Curium INDIUM IN 111 CHLORIDE indium in-111 chloride INJECTABLE;INJECTION 019841-001 Sep 27, 1994 RX Yes Yes   Start Trial   Start Trial
Curium SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016515-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Curium OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 RX Yes Yes   Start Trial   Start Trial
Curium ULTRA-TECHNEKOW FM technetium tc-99m sodium pertechnetate generator SOLUTION;INTRAVENOUS 017243-003 Feb 18, 2014 RX Yes Yes   Start Trial   Start Trial
Curium XENON XE 133 xenon xe-133 GAS;INHALATION 018327-002 Mar 9, 1982 RX No No   Start Trial   Start Trial
Curium TECHNESCAN PYP KIT technetium tc-99m pyrophosphate kit INJECTABLE;INJECTION 017538-001 Approved Prior to Jan 1, 1982 AP RX No No   Start Trial   Start Trial
Curium SODIUM CHROMATE CR 51 sodium chromate cr-51 INJECTABLE;INJECTION 016708-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Curium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Curium OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 5,384,113   Start Trial
Curium OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 6,123,916   Start Trial
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 4,432,963   Start Trial
Curium ULTRATAG technetium tc-99m red blood cell kit INJECTABLE;INJECTION 019981-001 Jun 10, 1991 4,755,375   Start Trial
Curium TECHNESCAN MAG3 technetium tc-99m mertiatide kit INJECTABLE;INJECTION 019882-001 Jun 15, 1990 5,573,748   Start Trial
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 4,497,744   Start Trial
Curium OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 5,776,894   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Merck
Boehringer Ingelheim
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.